Literature DB >> 7494806

Effects of insulin concentration and self-association on the partitioning of its A-21 cyclic anhydride intermediate to desamido insulin and covalent dimer.

R T Darrington1, B D Anderson.   

Abstract

PURPOSE: In the pH range 2-5, human insulin degrades via deamidation at the A-21 asn and covalent dimerization. Both products form via a common cyclic anhydride intermediate, a product of intramolecular neucleophilic attack by the A-21 carboxyl terminus. This study examines the influence of [insulin] and self-association on the partitioning of the intermediate to products.
METHODS: Insulin self-association was characterized (pH 2-4) by concentration difference spectroscopy. Deamination rates (pH 2-4) and concurrent rates of covalent dimer formation (pH 4) were determined versus [insulin] at 35 degrees C by initial rates. A mathematical model was developed to account for the overall rate and product composition profile versus pH and [insulin].
RESULTS: Between pH 2-4, insulin self-associates to form non-covalent dimers with a pH independent association constant of 1.8 x 10(4) M-1. The overall rate of degradation is governed by intermediate formation, while product distribution is determined by competition between water and the phe B-1 amino group of insulin for the anhydride. In dilute solutions, deamidation is first-order in [insulin] while covalent dimerization is second-order. Thus, deamidation predominates in dilute solutions but the fraction of covalent dimer formed increases with [insulin]. At high [insulin], self-association inhibits covalent dimer formation, preventing exclusive degradation via this pathway. The model accurately predicts a maximum in covalent dimer formation near pH 4.
CONCLUSIONS: A mechanism is described which accounts for the complex dependence of insulin's degradation rate and product distribution profile on pH (between 2-5) and [insulin]. If these results can be generalized, they suggest that covalent aggregation in proteins may be inhibited by self-association.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494806     DOI: 10.1023/a:1016231019677

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  1H NMR spectrum of the native human insulin monomer. Evidence for conformational differences between the monomer and aggregated forms.

Authors:  M Roy; R W Lee; J Brange; M F Dunn
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

2.  Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30.

Authors:  J Markussen; I Diers; P Hougaard; L Langkjaer; K Norris; L Snel; A R Sørensen; E Sørensen; H O Voigt
Journal:  Protein Eng       Date:  1988-07

3.  Chemical, physical, and biological characterization of a dimeric form of biosynthetic human growth hormone.

Authors:  G W Becker; R R Bowsher; W C Mackellar; M L Poor; P M Tackitt; R M Riggin
Journal:  Biotechnol Appl Biochem       Date:  1987-12       Impact factor: 2.431

4.  The structure of 2Zn pig insulin crystals at 1.5 A resolution.

Authors:  E N Baker; T L Blundell; J F Cutfield; S M Cutfield; E J Dodson; G G Dodson; D M Hodgkin; R E Hubbard; N W Isaacs; C D Reynolds
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1988-07-06       Impact factor: 6.237

5.  Role of aggregated human growth hormone (hGH) in development of antibodies to hGH.

Authors:  W V Moore; P Leppert
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

6.  Insulin-metal ion interactions: the binding of divalent cations to insulin hexamers and tetramers and the assembly of insulin hexamers.

Authors:  F D Coffman; M F Dunn
Journal:  Biochemistry       Date:  1988-08-09       Impact factor: 3.162

7.  Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates.

Authors:  R E Ratner; T M Phillips; M Steiner
Journal:  Diabetes       Date:  1990-06       Impact factor: 9.461

8.  The source of the circulating aggregate of insulin in type I diabetic patients is therapeutic insulin.

Authors:  M Maislos; P M Mead; D H Gaynor; D C Robbins
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

9.  Stability of interleukin 1 beta (IL-1 beta) in aqueous solution: analytical methods, kinetics, products, and solution formulation implications.

Authors:  L C Gu; E A Erdös; H S Chiang; T Calderwood; K Tsai; G C Visor; J Duffy; W C Hsu; L C Foster
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

10.  Comparative study of biosynthetic human growth hormone immunogenicity in growth hormone deficient children.

Authors:  C Rougeot; P Marchand; F Dray; F Girard; J C Job; M Pierson; C Ponte; P Rochiccioli; R Rappaport
Journal:  Horm Res       Date:  1991
View more
  10 in total

1.  Kinetics and mechanisms of deamidation and covalent amide-linked adduct formation in amorphous lyophiles of a model asparagine-containing Peptide.

Authors:  Michael P Dehart; Bradley D Anderson
Journal:  Pharm Res       Date:  2011-10-18       Impact factor: 4.200

2.  Purification and identification of high molecular weight products formed during storage of neutral formulation of human insulin.

Authors:  Christian Fogt Hjorth; František Hubálek; Jonatan Andersson; Christian Poulsen; Daniel Otzen; Helle Naver
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200

3.  Mass Spectrometry Based Mechanistic Insights into Formation of Tris Conjugates: Implications on Protein Biopharmaceutics.

Authors:  Pradeep G Kabadi; Praveen Kallamvalliillam Sankaran; Dinesh V Palanivelu; Laxmi Adhikary; Anand Khedkar; Amarnath Chatterjee
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-03       Impact factor: 3.109

4.  Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions.

Authors:  R G Strickley; B D Anderson
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

5.  Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues.

Authors:  Ugo Bilati; Eric Allémann; Eric Doelker
Journal:  AAPS PharmSciTech       Date:  2005-12-01       Impact factor: 3.246

6.  Beta-relaxation of insulin molecule in lyophilized formulations containing trehalose or dextran as a determinant of chemical reactivity.

Authors:  Sumie Yoshioka; Tamaki Miyazaki; Yukio Aso
Journal:  Pharm Res       Date:  2006-05-02       Impact factor: 4.200

7.  A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations.

Authors:  Sumie Yoshioka; Yukio Aso
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

8.  Effect of ethylenediamine on chemical degradation of insulin aspart in pharmaceutical solutions.

Authors:  Christian Poulsen; Dorte Jacobsen; Lisbeth Palm
Journal:  Pharm Res       Date:  2008-07-08       Impact factor: 4.200

9.  Structure of human insulin monomer in water/acetonitrile solution.

Authors:  Wojciech Bocian; Jerzy Sitkowski; Elzbieta Bednarek; Anna Tarnowska; Robert Kawecki; Lech Kozerski
Journal:  J Biomol NMR       Date:  2007-11-27       Impact factor: 2.835

Review 10.  Thiyl Radical Reactions in the Chemical Degradation of Pharmaceutical Proteins.

Authors:  Christian Schöneich
Journal:  Molecules       Date:  2019-11-28       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.